Six Oropouche Virus Disease Cases Confirmed in Europe

According to the European CDC, Italy and Spain each reported three confirmed cases of Oropouche virus disease in travelers returning from Cuba.

The ECDC stated on July 12, 2024, that the likelihood of secondary transmission of the Oropouche virus within continental Europe is considered very low due to the absence of known competent vectors, midges (small flies), and mosquitoes, commonly found in the Region of the Americas.

To alert international travelers, the U.S. CDC issued a Level 1 Travel Health Advisory in June 2024. This advisory stated that people should seek medical care if they develop high fever, headache, muscle aches, stiff joints, nausea, vomiting, chills, or sensitivity to light during or after travel.

As of July 23, 2024, no U.S. FDA-approved vaccines for Oropouche virus disease exist.